Clinical Trial Update: Effects of a CRF1 Receptor Antagonist on Human Startle in Normal Female Volunteers

View source ↗

Summary

This clinical trial update reports a completed study evaluating how a CRF1 receptor antagonist affects startle responses in healthy female volunteers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders

Drugs mentioned

• CRF1 receptor antagonist (CRF1 receptor antagonist)

Snippet

Sponsor: National Institute of Mental Health (NIMH) | Conditions: Anxiety Disorders | Status: COMPLETED